Cargando…
Beta-Blockers in COVID-ARDS: Inflammation or Hemodynamic?
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
by the American College of Cardiology Foundation. Published by Elsevier.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8722639/ https://www.ncbi.nlm.nih.gov/pubmed/34991792 http://dx.doi.org/10.1016/j.jacc.2021.09.1384 |
_version_ | 1784625554999214080 |
---|---|
author | de Roquetaillade, Charles Guillemin, Jérémie Beaucoté, Victor Barthelemy, Romain Chousterman, Benjamin Glenn |
author_facet | de Roquetaillade, Charles Guillemin, Jérémie Beaucoté, Victor Barthelemy, Romain Chousterman, Benjamin Glenn |
author_sort | de Roquetaillade, Charles |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-8722639 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | by the American College of Cardiology Foundation. Published by Elsevier. |
record_format | MEDLINE/PubMed |
spelling | pubmed-87226392022-01-04 Beta-Blockers in COVID-ARDS: Inflammation or Hemodynamic? de Roquetaillade, Charles Guillemin, Jérémie Beaucoté, Victor Barthelemy, Romain Chousterman, Benjamin Glenn J Am Coll Cardiol Letter by the American College of Cardiology Foundation. Published by Elsevier. 2022 2022-01-03 /pmc/articles/PMC8722639/ /pubmed/34991792 http://dx.doi.org/10.1016/j.jacc.2021.09.1384 Text en © 2022 by the American College of Cardiology Foundation. Published by Elsevier. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Letter de Roquetaillade, Charles Guillemin, Jérémie Beaucoté, Victor Barthelemy, Romain Chousterman, Benjamin Glenn Beta-Blockers in COVID-ARDS: Inflammation or Hemodynamic? |
title | Beta-Blockers in COVID-ARDS: Inflammation or Hemodynamic? |
title_full | Beta-Blockers in COVID-ARDS: Inflammation or Hemodynamic? |
title_fullStr | Beta-Blockers in COVID-ARDS: Inflammation or Hemodynamic? |
title_full_unstemmed | Beta-Blockers in COVID-ARDS: Inflammation or Hemodynamic? |
title_short | Beta-Blockers in COVID-ARDS: Inflammation or Hemodynamic? |
title_sort | beta-blockers in covid-ards: inflammation or hemodynamic? |
topic | Letter |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8722639/ https://www.ncbi.nlm.nih.gov/pubmed/34991792 http://dx.doi.org/10.1016/j.jacc.2021.09.1384 |
work_keys_str_mv | AT deroquetailladecharles betablockersincovidardsinflammationorhemodynamic AT guilleminjeremie betablockersincovidardsinflammationorhemodynamic AT beaucotevictor betablockersincovidardsinflammationorhemodynamic AT barthelemyromain betablockersincovidardsinflammationorhemodynamic AT choustermanbenjaminglenn betablockersincovidardsinflammationorhemodynamic |